Search results
-
Blog
Case Study: Achieving a 505(b)(2) Regulatory Approval for Multiple NDA-Enabling Studies
See how Altasciences supported a sponsor’s 505(b)(2) submission with three pivotal studies, driving simulation, bioavailability, and dose-escalation, to deliver critical data.
-
Blog
Altasciences At CPHI Americas 2025 | By Lisa Sanford
Lisa Sanford reflects on CPHI Americas 2025, where Altasciences unveiled new spray drying technology.
-
Blog
Getting to the Heart of Science: How Clinical Research Saved My Life and Continues to Inspire Me
Research Laboratory Technician Josiah Liang opens up about how clinical research has profoundly impacted his life and shaped his career in the field.
-
Blog
Optimizing for Success: How Sponsors Can Overcome the Challenges in Early-Phase Drug Development
Early-phase drug development is a complex process. Discover how Altasciences, as an integrated CRO/CDMO, alleviates the challenges and reduces risks.
-
Blog
Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit
Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.
-
Blog
Pharmacokinetics, Pharmacodynamics and Toxicokinetics Demystified
Delve into the core of pharmacokinetics, pharmacodynamics, and toxicokinetics with Altasciences. Uncover the intricate relations that drive drug discovery and development with an engaging exploration.